CSE1L and hepatocellular carcinoma: Other studies of ours also showed that interferon-γ treatment increased CSE1L expression in cancer cells [23] and interferon-γ co-treatment enhanced doxorubicin-induced p53 accumulation of Hep G2 hepatoma cells [32].